Skip to main content
Top
Published in: Globalization and Health 1/2018

Open Access 01-12-2018 | Debate

Challenges and dilemmas on universal coverage for non-communicable diseases in middle-income countries: evidence and lessons from Mexico

Authors: Armando Arredondo, Alejandra Azar, Ana Lucia Recaman

Published in: Globalization and Health | Issue 1/2018

Login to get access

Abstract

Background

Despite more than 20 years of reform projects in health systems, the universal coverage strategy has not reached the expected results in most middle-income countries (MICs). Using evidence from the Mexican case on diabetes and hypertension as tracers of non-communicable diseases, the effective coverage rate barely surpasses half of the expected goals necessary to meet the challenges that these two diseases represent at the population level. Prevalence and incidence rates do not diminish either; they even grow. In terms of the economic burden, this means that lack of financial protection and catastrophic expense rates have increased, contrary to what could have been expected.

Discussion

As any complex system, health systems present challenges and dilemmas that are difficult to solve. In terms of universal coverage, when contrasting normative coverage versus effective coverage, the epidemiological, cultural, organizational and economic challenges and barriers become evident. Such challenges have not allowed a greater effectiveness of the contributions of state of the art medicine in the resolution of health problems, particularly in relation to diabetes and hypertension.

Conclusions

Despite of the existence of many universal coverage projects, strategies and programs implemented in MICs, challenges remain and, far from disappearing, unresolved problems are still present, even with increasing trends. The model of care based on a curative biomedical approach was enough to respond to the health needs of the last century, but is no longer adapted to the needs of the present century. The dilemmas of continuity vs. rupture require to review and discuss the background and structure of health systems and their underlying models of care. These two elements have not allowed the different coverage schemes to guarantee greater effectiveness in the application of state of the art medicine, nor a greater health care financial protection for patients and their families. We thus can either accept the fragmented health systems and bio-medical-curative models of care approach or, instead, we can move towards integrated health systems that would be based on a socio-medical-preventive approach to health care.
Literature
1.
go back to reference Sojo A. Condiciones para el acceso universal a la salud en América Latina: derechos sociales, protección social y restricciones financieras y políticas Ciência & Saúde Coletiva. Cien Saude Colet. 2011;16(6):2673–85.CrossRef Sojo A. Condiciones para el acceso universal a la salud en América Latina: derechos sociales, protección social y restricciones financieras y políticas Ciência & Saúde Coletiva. Cien Saude Colet. 2011;16(6):2673–85.CrossRef
3.
go back to reference Tamez González S, Eibenschutz C. Popular Health Insurance: key piece of inequity in health in Mexico Silvia. Rev. salud pública. 2008, Vol 10 sup (1): 133–145. Tamez González S, Eibenschutz C. Popular Health Insurance: key piece of inequity in health in Mexico Silvia. Rev. salud pública. 2008, Vol 10 sup (1): 133–145.
4.
go back to reference WHO. World Health Report. Health systems financing. Path to universal coverage. Geneva: World Health Organization. 2010;2010:12–24. WHO. World Health Report. Health systems financing. Path to universal coverage. Geneva: World Health Organization. 2010;2010:12–24.
6.
go back to reference Estevez R. The quest for equity in Latin America: a comparative analysis of the health care reforms in Brazil and Colombia. International J Equity and Health. 2012;11:6.CrossRef Estevez R. The quest for equity in Latin America: a comparative analysis of the health care reforms in Brazil and Colombia. International J Equity and Health. 2012;11:6.CrossRef
7.
go back to reference Benedict R, et al. Universal coverage, priority setting, and the human right to health. Lancet. 2017;390(10095):712–4.CrossRef Benedict R, et al. Universal coverage, priority setting, and the human right to health. Lancet. 2017;390(10095):712–4.CrossRef
8.
go back to reference Bennett S, Ozawa S, Rao KD. Which path to universal health coverage? Perspectives on the world health report 2010. PLoS Med. 2010;7:e1001001.CrossRef Bennett S, Ozawa S, Rao KD. Which path to universal health coverage? Perspectives on the world health report 2010. PLoS Med. 2010;7:e1001001.CrossRef
9.
go back to reference SSA informes Salud 2000–2010. Mexico. Secretaría de Salud de México: información para la rendición de cuentas, Secretaría de Salud, México, DF, 2010: 32–52. SSA informes Salud 2000–2010. Mexico. Secretaría de Salud de México: información para la rendición de cuentas, Secretaría de Salud, México, DF, 2010: 32–52.
10.
go back to reference SSA-Secretaría de Salud. Programa Nacional de Salud 2001-2006. La democratización de la salud en México: Hacia un sistema universal de salud. México: Secretaría de Salud. p. 2007. SSA-Secretaría de Salud. Programa Nacional de Salud 2001-2006. La democratización de la salud en México: Hacia un sistema universal de salud. México: Secretaría de Salud. p. 2007.
11.
go back to reference The world health report. Research for universal health coverage. Geneva: World Health Organization; 2013. The world health report. Research for universal health coverage. Geneva: World Health Organization; 2013.
13.
go back to reference World Bank. Universal healthcare on the rise in Latin America. Washington D.C: Working Paper; 2013. World Bank. Universal healthcare on the rise in Latin America. Washington D.C: Working Paper; 2013.
15.
go back to reference Suarez J. Desafíos para alcanzar universalidad con equidad en salud en América Latina en el siglo XXI. Revista Cubana de Salud Pública. 2010;36(3):248–54.CrossRef Suarez J. Desafíos para alcanzar universalidad con equidad en salud en América Latina en el siglo XXI. Revista Cubana de Salud Pública. 2010;36(3):248–54.CrossRef
16.
go back to reference NIPH. National Institute of public health. Project: costs and financing consequences from changes in epidemiological profile on chronic diseases. Final Technical Report. 1995-2016;2017:18–22. NIPH. National Institute of public health. Project: costs and financing consequences from changes in epidemiological profile on chronic diseases. Final Technical Report. 1995-2016;2017:18–22.
17.
go back to reference Arredondo A, Avilés R. Costs and Epidemiological Changes of Chronic Diseases: Implications and Challenges for Health Systems. Rev. Plos One. 2016;10(3):e0118611.CrossRef Arredondo A, Avilés R. Costs and Epidemiological Changes of Chronic Diseases: Implications and Challenges for Health Systems. Rev. Plos One. 2016;10(3):e0118611.CrossRef
18.
go back to reference American Diabetes Association. Metabolic Contrasts between Youth and Adults with Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes: I. Observations Using the Hyperglycemic Clamp. Diabetes Care. 2018:1–10. https://doi.org/10.2337/dc18-0244 American Diabetes Association. Metabolic Contrasts between Youth and Adults with Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes: I. Observations Using the Hyperglycemic Clamp. Diabetes Care. 2018:1–10. https://​doi.​org/​10.​2337/​dc18-0244
19.
go back to reference Carey R, Whelton P. The 2017 American College of Cardiology/American Heart Association hypertension guideline: a resource for practicing clinicians. Ann Intern Med. 2018;168(5):359–60.CrossRef Carey R, Whelton P. The 2017 American College of Cardiology/American Heart Association hypertension guideline: a resource for practicing clinicians. Ann Intern Med. 2018;168(5):359–60.CrossRef
20.
go back to reference Arredondo A. Diabetes duration, HbA1c, and cause-specific mortality in Mexico. Lancet Diabetes & Endocrinology. 2018;6(6):429–31.CrossRef Arredondo A. Diabetes duration, HbA1c, and cause-specific mortality in Mexico. Lancet Diabetes & Endocrinology. 2018;6(6):429–31.CrossRef
23.
go back to reference de Salud S. In: de Salud S, editor. Programa de Reforma del Sector Salud, 2007-2012, vol. 2016. México: Poder Ejecutivo Federal; 2013-2018. p. 1–56. de Salud S. In: de Salud S, editor. Programa de Reforma del Sector Salud, 2007-2012, vol. 2016. México: Poder Ejecutivo Federal; 2013-2018. p. 1–56.
24.
go back to reference National Institute of Public Health. Métodos de estimación de cambios epidemiológicos y demanda esperada de enfermedades crónico-degenerativas. México: Informe Técnico de Memoria Metodológica. Cuernavaca; 2015. p. 12–23. National Institute of Public Health. Métodos de estimación de cambios epidemiológicos y demanda esperada de enfermedades crónico-degenerativas. México: Informe Técnico de Memoria Metodológica. Cuernavaca; 2015. p. 12–23.
25.
go back to reference Zhang P, Zhang X, Brown J, Vistisen D, Sicree R. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Research. 2010;87:293–301. Zhang P, Zhang X, Brown J, Vistisen D, Sicree R. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Research. 2010;87:293–301.
26.
go back to reference Barcelo A, Arredondo A, Escobar A, Quiang A. The cost of diabetes in Latin America and the Caribbean in 2015: evidence for decision and policy makers. Jou of Global Health. 2017;7(2):1–15. Barcelo A, Arredondo A, Escobar A, Quiang A. The cost of diabetes in Latin America and the Caribbean in 2015: evidence for decision and policy makers. Jou of Global Health. 2017;7(2):1–15.
27.
go back to reference Arredondo A, Aviles R, Costs and Epidemiological Changes of Chronic Diseases: Implications and Challenges for Health Systems. Plos One, 2015 (10), Num 3 e0118611. Arredondo A, Aviles R, Costs and Epidemiological Changes of Chronic Diseases: Implications and Challenges for Health Systems. Plos One, 2015 (10), Num 3 e0118611.
28.
go back to reference Gutiérrez JP, Hernández-Ávila M. Cobertura de protección en salud en México, 2000–2012. Salud Publica Mex 2013;55(supl 2):S83-S90. Gutiérrez JP, Hernández-Ávila M. Cobertura de protección en salud en México, 2000–2012. Salud Publica Mex 2013;55(supl 2):S83-S90.
30.
go back to reference Fajardo-Dolci G, Gutiérrez JP, García-Saisó S. Effective access to health services: operationalizing universal health coverage. Salud Publica Mex. 2015;57:180–6.CrossRef Fajardo-Dolci G, Gutiérrez JP, García-Saisó S. Effective access to health services: operationalizing universal health coverage. Salud Publica Mex. 2015;57:180–6.CrossRef
31.
go back to reference National Academy of Medicine. Acciones para enfrentar la diabetes. Impacto Economico de la diabetes, retos y soluciones. Mexico: NAM Ed; 2014. p. 269–86. National Academy of Medicine. Acciones para enfrentar la diabetes. Impacto Economico de la diabetes, retos y soluciones. Mexico: NAM Ed; 2014. p. 269–86.
32.
go back to reference National Institute of Public Health. Métodos de estimación de cambios epidemiológicos y demanda esperada de enfermedades crónico-degenerativas. México: Informe Técnico de Memoria Metodológica. Cuernavaca; 2015. p. 30–7. National Institute of Public Health. Métodos de estimación de cambios epidemiológicos y demanda esperada de enfermedades crónico-degenerativas. México: Informe Técnico de Memoria Metodológica. Cuernavaca; 2015. p. 30–7.
35.
go back to reference Bleich SN, Cutler DM, Adams AS, Lozano R, Murray CJL. Impact of insurance and supply of health professionals on coverage of treatment for hypertension in Mexico: population based study. Br Med J. 2007;335:875.CrossRef Bleich SN, Cutler DM, Adams AS, Lozano R, Murray CJL. Impact of insurance and supply of health professionals on coverage of treatment for hypertension in Mexico: population based study. Br Med J. 2007;335:875.CrossRef
36.
go back to reference Reddy KS, Patel V, Jha P, Paul VK, Shiva Kumar AK, Dandona L. Towards achievement of universal health care in India by 2020: a call toaction. Lancet. 2012;377:760–8.CrossRef Reddy KS, Patel V, Jha P, Paul VK, Shiva Kumar AK, Dandona L. Towards achievement of universal health care in India by 2020: a call toaction. Lancet. 2012;377:760–8.CrossRef
37.
go back to reference Boerma T, AbouZahr C, Evans D, Evans T. Monitoring intervention coverage in the context of universal health coverage. PLoS Med. 2014;11:e1001728.CrossRef Boerma T, AbouZahr C, Evans D, Evans T. Monitoring intervention coverage in the context of universal health coverage. PLoS Med. 2014;11:e1001728.CrossRef
40.
go back to reference Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. Milbank Memorial Fund Quaterly. 1971;49:509–38.CrossRef Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. Milbank Memorial Fund Quaterly. 1971;49:509–38.CrossRef
41.
go back to reference Frenk J, Bobadilla JL, Stern C, Lozano R. The epidemiological transition in Latin America. Bol Oficina Sanit Panam. 1991;111:485–96.PubMed Frenk J, Bobadilla JL, Stern C, Lozano R. The epidemiological transition in Latin America. Bol Oficina Sanit Panam. 1991;111:485–96.PubMed
42.
go back to reference Olshansky SJ, Ault AB. The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases. Milbank Q. 1986;64:355–91.CrossRef Olshansky SJ, Ault AB. The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases. Milbank Q. 1986;64:355–91.CrossRef
43.
go back to reference Porter M. A strategy for health care reform. Toward a value-based system. N Engl J Med. 2009;361:109–12.CrossRef Porter M. A strategy for health care reform. Toward a value-based system. N Engl J Med. 2009;361:109–12.CrossRef
44.
go back to reference Cortez R, Romero D. Increasing utilization of health care services among the uninsured population: the plan Nacer program. Working paper no. 74956. World Bank Series: Buenos Aires; 2013. Cortez R, Romero D. Increasing utilization of health care services among the uninsured population: the plan Nacer program. Working paper no. 74956. World Bank Series: Buenos Aires; 2013.
45.
go back to reference Arredondo A. Changing paradigms and challenges: evidence on the epidemiological and economic burden of diabetes in Latin America. Diabet Med. 2017;34(7):1009–10.CrossRef Arredondo A. Changing paradigms and challenges: evidence on the epidemiological and economic burden of diabetes in Latin America. Diabet Med. 2017;34(7):1009–10.CrossRef
46.
go back to reference Giedion U. Designing and implementing explicit health benefits packages in Latin America. In: In Report of the Roundtable Discussion on Universal Health Coverage. Washington D.C: Policy Wisdom; 2013. p. 6–7. Giedion U. Designing and implementing explicit health benefits packages in Latin America. In: In Report of the Roundtable Discussion on Universal Health Coverage. Washington D.C: Policy Wisdom; 2013. p. 6–7.
47.
go back to reference Barzansky B.Abraham Flexner and the era of medical education reform. Acad Med 2010 Sep;85(9Suppl):S19–S25. Barzansky B.Abraham Flexner and the era of medical education reform. Acad Med 2010 Sep;85(9Suppl):S19–S25.
48.
go back to reference Monteiro de Andrade LO, Pellegrini Filho A, Solar O, Rígoli F, Malagón de Salazar L, Pastor Castell-Florit, et al. Determinantes sociales de salud, cobertura universal de salud, y desarrollo sostenible: estudios de casos en países latinoamericanos. MEDICC Rev. 2015;17 Suppl:S53–S61. Monteiro de Andrade LO, Pellegrini Filho A, Solar O, Rígoli F, Malagón de Salazar L, Pastor Castell-Florit, et al. Determinantes sociales de salud, cobertura universal de salud, y desarrollo sostenible: estudios de casos en países latinoamericanos. MEDICC Rev. 2015;17 Suppl:S53–S61.
49.
go back to reference WHO. Closing the gap: Policy into practice on social determinants of health. In: de Janeiro R, editor. World conference on social Determinants of Health. Rio de Janeiro: WHO; 2011. p. 47. WHO. Closing the gap: Policy into practice on social determinants of health. In: de Janeiro R, editor. World conference on social Determinants of Health. Rio de Janeiro: WHO; 2011. p. 47.
51.
go back to reference WHO-World Bank. Tracking universal health coverage: first global monitoring report. In: Universal Coverage and Healthcare Financing. Health Services Accessibility, Monitoring Financial Protection. Geneve: WHO; 2015. p. 18–56. WHO-World Bank. Tracking universal health coverage: first global monitoring report. In: Universal Coverage and Healthcare Financing. Health Services Accessibility, Monitoring Financial Protection. Geneve: WHO; 2015. p. 18–56.
52.
go back to reference Rodin J, de Ferranti D. Universal health coverage: the third global health transition? Lancet. 2012;380:861–2.CrossRef Rodin J, de Ferranti D. Universal health coverage: the third global health transition? Lancet. 2012;380:861–2.CrossRef
53.
go back to reference Lai T, Habicht T, Jesse M. Monitoring and evaluating progress towards universal health coverage in Estonia. PLoS Med. 2014;11(9):e1001677.CrossRef Lai T, Habicht T, Jesse M. Monitoring and evaluating progress towards universal health coverage in Estonia. PLoS Med. 2014;11(9):e1001677.CrossRef
54.
go back to reference Arredondo A, Orozco E, Alcalde J, Navarro J. Carga económica y epidemiológica de Diabetes e Hipertension en México. Saud Pub de Brasil. 2018;52:1–23.CrossRef Arredondo A, Orozco E, Alcalde J, Navarro J. Carga económica y epidemiológica de Diabetes e Hipertension en México. Saud Pub de Brasil. 2018;52:1–23.CrossRef
55.
go back to reference Arredondo A. Type 2 diabetes and health care costs in Latin America: exploring the need for greater preventive medicine. BMC Med. 2014;12(136):11–9. Arredondo A. Type 2 diabetes and health care costs in Latin America: exploring the need for greater preventive medicine. BMC Med. 2014;12(136):11–9.
Metadata
Title
Challenges and dilemmas on universal coverage for non-communicable diseases in middle-income countries: evidence and lessons from Mexico
Authors
Armando Arredondo
Alejandra Azar
Ana Lucia Recaman
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Globalization and Health / Issue 1/2018
Electronic ISSN: 1744-8603
DOI
https://doi.org/10.1186/s12992-018-0404-3

Other articles of this Issue 1/2018

Globalization and Health 1/2018 Go to the issue